Sionna Therapeutics Presents Preclinical Data at 2023 North American Cystic Fibrosis Conference Demonstrating Series 2 NBD1 Stabilizers Normalize ΔF508-CFTR Function ...Middle East

PR Newswire - News
- SION-719 and SION-451, combined with complementary CFTR modulators, fully restore ΔF508-CFTR maturation, trafficking, and function to wild-type levels in CFHBE model and other preclinical systems - BOSTON, Nov. 3, 2023 /PRNewswire/ -- Sionna Therapeutics, a clinical-stage life sciences...

Hence then, the article about sionna therapeutics presents preclinical data at 2023 north american cystic fibrosis conference demonstrating series 2 nbd1 stabilizers normalize df508 cftr function was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sionna Therapeutics Presents Preclinical Data at 2023 North American Cystic Fibrosis Conference Demonstrating Series 2 NBD1 Stabilizers Normalize ΔF508-CFTR Function )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News